CRISPR-Cas Solutions Pioneer
Together with a team of 14 bio-engineers, scientist and experts Niek Savelkoul, CEO and Founder of Scope Biosciences, is set out to accelerate onsite molecular diagnostics. Niek holds a Masters degree (MSc) in Biotechnology and previously worked as a Business Developer at Wageningen University & Research.
Onsite molecular diagnostics with extreme accuracy
With the capability of detecting single nucleotide differences and a CRISPR-Cas based test sensitive enough to detect the smallest amount of genetic material, the scopeDx® platform of Scope Biosciences is on another level when it comes to accuracy. And all that while there is no need for a laboratory, scopeDx® is a simple-to-use test to be used on-site. The platform can identify any DNA or RNA target in plants, to help seed producers and other players in the Agriculture industry in a wide variety of application areas like helping to detect pathogens fast and on-site or excluding the presence of biological adulterants in products.
